These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18841028)

  • 41. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection.
    van der Meer AJ; Veldt BJ; Feld JJ; Wedemeyer H; Dufour JF; Lammert F; Duarte-Rojo A; Manns MP; Zeuzem S; Hofmann WP; de Knegt RJ; Hansen BE; Janssen HL
    J Viral Hepat; 2014 Aug; 21(8):568-77. PubMed ID: 24118177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alpha.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Nakano S; Arakawa T; Fujimori M
    J Med Virol; 2009 Aug; 81(8):1354-62. PubMed ID: 19551828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Determination of the type and subtype of the hepatitis C virus in chronic viral hepatitis patients in Hungary].
    Gervain J; Simon G; Papp I; Szabóné BK
    Orv Hetil; 2001 Jun; 142(25):1315-9. PubMed ID: 11488211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors that predict the response to interferon in patients with chronic hepatitis C: clinical management of individual patients.
    Lo Iacono O
    Rev Esp Enferm Dig; 2000 Aug; 92(8):485-94. PubMed ID: 11084816
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
    Muir AJ; Sylvestre PB; Rockey DC
    J Viral Hepat; 2006 May; 13(5):322-8. PubMed ID: 16637863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area.
    Mariano A; Caserta C; Pendino GM; Vacalebre C; Surace P; Fiorillo MT; Polito I; Surace M; Alicante S; Amante A; Foti G; Marra M; Gutamo G; Amato F; Messineo A; Mele A
    Dig Liver Dis; 2009 Jul; 41(7):509-15. PubMed ID: 19196557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.
    Hamano K; Seo Y; Kato H; Kato M; Yano Y; Ninomiya T; Kasuga M
    Int J Mol Med; 2006 Jun; 17(6):989-95. PubMed ID: 16685406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.
    Bruno S; Crosignani A; Facciotto C; Rossi S; Roffi L; Redaelli A; de Franchis R; Almasio PL; Maisonneuve P
    Hepatology; 2010 Jun; 51(6):2069-76. PubMed ID: 20196120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients.
    Ramos B; Núñez M; Toro C; Sheldon J; García-Samaniego J; Ríos P; Soriano V
    J Infect; 2007 Feb; 54(2):173-9. PubMed ID: 16569433
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2.
    Arase Y; Suzuki F; Sezaki H; Kawamura Y; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Yatsuji H; Hirakawa M; Kobayashi M; Saitoh S; Ikeda K; Kumada H
    Intern Med; 2009; 48(16):1337-42. PubMed ID: 19687576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism.
    Oh HB; Kim SO; Cha CH; Hong SP; Folk WR; Kim KM; Suh DJ
    J Med Virol; 2008 Oct; 80(10):1712-9. PubMed ID: 18712825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.
    Arase Y; Suzuki F; Suzuki Y; Akuta N; Kobayashi M; Sezaki H; Hosaka T; Kawamura Y; Yatsuji H; Hirakawa M; Ikeda K; Hsieh SD; Oomoto Y; Amakawa K; Kato H; Kazawa T; Tsuji H; Kobayashi T; Kumada H
    J Med Virol; 2010 Mar; 82(3):390-5. PubMed ID: 20087925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C.
    Dai CY; Chuang WL; Hsieh MY; Lee LP; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
    Transl Res; 2006 Sep; 148(3):128-33. PubMed ID: 16938650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice?
    Jain A; Menegus M; Mohanka R; Orloff M; Abt P; Mantry P; Bozorgzadeh A
    Exp Clin Transplant; 2006 Jun; 4(1):475-80. PubMed ID: 16827647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.
    Hamed MR; Tarr AW; McClure CP; Ball JK; Hickling TP; Irving WL
    J Viral Hepat; 2008 May; 15(5):339-45. PubMed ID: 18221305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection.
    Uka K; Suzuki F; Akuta N; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2006 May; 41(5):470-5. PubMed ID: 16799889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genotypic characterization of hepatitis C virus and its significance in patients with chronic liver disease from Northern India.
    Verma V; Chakravarti A; Kar P
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):408-14. PubMed ID: 18455899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attachment of hepatitis C virus to cultured cells: a novel predictive factor for successful interferon therapy.
    Kimura Y; Hayashida K; Ishibashi H; Niho Y; Akazawa K; Yanagi Y
    J Med Virol; 1998 Sep; 56(1):25-32. PubMed ID: 9700629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Distribution of hepatitis C virus genotypes in Jeju Island].
    Lee H; Cho YK; Kim HU; Choi EK; Hyun S; Kang D; Jeong SU; Kim HJ; Kim KS; Song BC
    Korean J Hepatol; 2008 Mar; 14(1):28-35. PubMed ID: 18367855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.